These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36798048)

  • 1. Long-term prolonged-release tacrolimus outcomes in living donor kidney transplantation: The Japan Academic Consortium of Kidney Transplantation study-II.
    Okumi M; Omoto K; Shimizu T; Shirakawa H; Unagami K; Lee T; Ishida H; Tanabe K; Takagi T
    Int J Urol; 2023 May; 30(5):483-491. PubMed ID: 36798048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
    Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
    Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction Therapy in Elderly Kidney Transplant Recipients With Low Immunological Risk.
    Masset C; Boucquemont J; Garandeau C; Buron F; Morelon E; Girerd S; Ladrière M; Mourad G; Garrigue V; Cassuto E; Albano L; Foucher Y; Dantal J;
    Transplantation; 2020 Mar; 104(3):613-622. PubMed ID: 31283665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-Onset Diabetes After Transplantation: Comparison Between a Cyclosporine-Based and a Tacrolimus-Based Immunosuppressive Regimen.
    Zolota A; Miserlis G; Solonaki F; Tranda A; Antoniadis N; Imvrios G; Fouzas I
    Transplant Proc; 2018 Dec; 50(10):3386-3391. PubMed ID: 30577210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
    Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
    Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure.
    Wojtusciszyn A; Mourad G; Bringer J; Renard E
    Diabetes Metab; 2013 Oct; 39(5):404-10. PubMed ID: 23999231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation): Impact of the Concentration-Dose Ratio on Death-censored Graft Survival.
    Jouve T; Fonrose X; Noble J; Janbon B; Fiard G; Malvezzi P; Stanke-Labesque F; Rostaing L
    Transplantation; 2020 Jun; 104(6):1263-1271. PubMed ID: 31415035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study.
    Okumi M; Unagami K; Hirai T; Shimizu T; Ishida H; Tanabe K;
    Int J Urol; 2017 Mar; 24(3):197-204. PubMed ID: 27862344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race.
    Soliman KM; Posadas Salas AC; Taber DJ
    Exp Clin Transplant; 2019 Dec; 17(6):707-713. PubMed ID: 30570456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frequency of T-cell mediated rejection in new-onset diabetes after kidney transplantation].
    Borda B; Szederkényi E; Lengyel C; Várkonyi T; Hódi Z; Kemény É; Szabó V; Lázár G
    Orv Hetil; 2015 May; 156(19):785-9. PubMed ID: 26039918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis for optimizing the modified release tacrolimus (Advagraf) after kidney transplantation: A prospective randomized trial.
    Bakr MA; Nagib AM; Donia AF; Denewar AA; Abu-Elmagd MM; Abbas MH; Abdel-Rahman AM; Mashaly ME; Elsaftawy MM; Ghoneim MA
    Saudi J Kidney Dis Transpl; 2018; 29(6):1267-1273. PubMed ID: 30588956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea.
    Baek CH; Kim JH; Yu H; Shin E; Cho H; Kim H; Yang WS; Han DJ; Park SK
    Exp Clin Transplant; 2016 Aug; 14(4):389-93. PubMed ID: 27228054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Machine Learning Consensus Clustering to Identify Distinct Subtypes of Black Kidney Transplant Recipients and Associated Outcomes.
    Thongprayoon C; Vaitla P; Jadlowiec CC; Leeaphorn N; Mao SA; Mao MA; Pattharanitima P; Bruminhent J; Khoury NJ; Garovic VD; Cooper M; Cheungpasitporn W
    JAMA Surg; 2022 Jul; 157(7):e221286. PubMed ID: 35507356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of calcineurin and mTOR inhibitors in kidney transplantation: a propensity score analysis based on current clinical practice.
    Cucchiari D; Ríos J; Molina-Andujar A; Montagud-Marrahi E; Revuelta I; Ventura-Aguiar P; Piñeiro GJ; De Sousa-Amorim E; Esforzado N; Cofán F; Torregrosa JV; Ugalde-Altamirano J; Ricart MJ; Rovira J; Torres F; Solè M; Campistol JM; Diekmann F; Oppenheimer F
    J Nephrol; 2020 Jun; 33(3):601-610. PubMed ID: 31853792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation.
    Rizzari MD; Suszynski TM; Gillingham KJ; Dunn TB; Ibrahim HN; Payne WD; Chinnakotla S; Finger EB; Sutherland DE; Kandaswamy R; Najarian JS; Pruett TL; Kukla A; Spong R; Matas AJ
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):494-503. PubMed ID: 22282482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients.
    Silva HT; Yang HC; Meier-Kriesche HU; Croy R; Holman J; Fitzsimmons WE; First MR
    Transplantation; 2014 Mar; 97(6):636-41. PubMed ID: 24521771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Calcineurin Inhibitor Choice on Outcomes in Kidney Transplant Recipients Aged ≥60 Y: A Collaborative Transplant Study Report.
    Echterdiek F; Döhler B; Latus J; Schwenger V; Süsal C
    Transplantation; 2022 Apr; 106(4):e212-e218. PubMed ID: 35066544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.